Objective To determine the long-term success of the periurethral injection
of collagen (Contigen (R) , Bard UK) in women with genuine stress incontine
nce.
Patients and methods Sixty-one women with genuine stress incontinence were
enrolled in a trial of periurethral collagen injections between 1 September
1990 and 31 August 1992. They were assessed at 1, 3, 6, 12 and 24 months a
fter the last collagen injection. In 1998, their notes were reviewed, and a
standardized questionnaire was sent to 46 women who were still alive and h
ad undergone no further anti-incontinence surgery.
Results Of the 53 women who were either known failures or who had follow-up
information beyond 5 years, 26% were subjectively improved. Women who had
a maximum urethral closure pressure of > 20 cmH(2)O and those who had urina
ry incontinence for < 10 years before their first injection were more likel
y to have had long-term success. There was no correlation between long-term
success and the number of previous operations, body mass index, age or pre
operative pad loss. Neither the number of injection sessions, total volume
of collagen injected nor perceived bulking at the time of surgery affected
long-term success rates. Of the 14 women who considered themselves subjecti
vely improved, seven had daily incontinence and only one was completely dry
. Urinary retention and urinary tract infection were the most common compli
cations. In addition, one woman reported a flare-up of her skin test and tr
ansient 'flu-like symptoms 2 weeks after the injection, and one woman devel
oped a right upper lobe pneumonia 2 weeks after the collagen injection.
Conclusion The long-term results of periurethral collagen injections are di
sappointing. We found no evidence to support the use of periurethral collag
en injections in women with intrinsic sphincter deficiency, who had a highe
r failure rate than those with hypermobility. Further research is essential
to develop agents that are not immunogenic, produce minimal inflammatory r
esponse and yet are durable.